CVS Health Corporation (CVS)

CVS Health Corporation (CVS) is a healthcare company (healthcare plans) based in the United States. The share price is $86.71, down 2.12% on the day, which values the company at $110.94B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$86.71−2.12% today
Market value
$110.94B
P/E ratio
10.1×last 12 months
Forward P/E
10.0×
Dividend yield
3.00%
Funk Score
47/100
Against its own history
Below its usual priceusual price $113.53
200-week average
$72.8519% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

CVS Health Corporation in more detail

CVS trades at 10.1× its last twelve months' earnings, 10.0× next year's expected earnings, 0.3× sales. Measured against its own history, the price is 24% below what its usual multiples would imply ($113.53) — below its usual price. It sits 19% above its 200-week average of $72.85.

Over the last five fiscal years CVS Health Corporation has compounded revenue 8.4% a year, earnings per share -23.9% a year, free cash flow -10.3% a year. Its Funk Score is 47 out of 100 (financial strength 2.6, profitability 3.2, growth 3.9, value 9.2, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Gross margin is shrinking.

22 of the superinvestors tracked here hold CVS, including Larry Robbins (10.0% of the portfolio), Prem Watsa (8.8% of the portfolio), Christopher Davis (4.4% of the portfolio).

Superinvestors holding CVS

22 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:CVS vs MRNA (CVS Health Corporation vs Moderna)CVS vs HCA (CVS Health Corporation vs HCA Healthcare)CVS vs GSK (CVS Health Corporation vs GSK)CVS vs SNY (CVS Health Corporation vs Sanofi)CVS vs MCK (CVS Health Corporation vs McKesson)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

CVS Health Corporation (CVS): questions and answers

What is CVS's P/E ratio?

CVS Health Corporation trades at 10.1× its last twelve months' earnings and 10.0× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 11.3× to 57.1×, with a median of 15.9×.

What is CVS's PEG ratio?

CVS Health Corporation's PEG ratio is 0.22 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is CVS Health Corporation's market cap?

CVS Health Corporation is valued at $110.94B at a share price of $86.71.

Is CVS overvalued or undervalued?

Against its own history, CVS is below its usual price: the price is 24% below the $113.53 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is CVS above its 200-week moving average?

Yes. CVS is 19.0% above its 200-week average of $72.85. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is CVS Health Corporation growing?

Over the last five fiscal years CVS Health Corporation's revenue grew 8.4% a year and its earnings per share -23.9% a year; over ten years revenue grew 10.1% a year.

Cite this page

Funkfolio, “CVS Health Corporation (CVS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CVS

Underlying data: Yahoo Finance; company filings with the SEC.